AptarGroup, Inc.

NYSE:ATR

Sector

🛍 Consumer Discretionary

Industries

🧴 Personal Care

🔬 Chemicals & Advanced Materials

💄 Cosmetics

💊 Drugstores & Retail Pharmacies

🛍 Specialty Retail

Location

United States

Market Cap

USD 9.93 B

Share Price

USD 150.30

Avg Daily Volume

351,553

Change (1 day)

0.40%

Change (1 year)

3.08%

Change (YTD)

-4.33%

AptarGroup, Inc. Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending March 31, 2025: USD 149.33 M

AptarGroup, Inc. Research and Development (R&D) Expenses is USD 149.33 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -73.83% change year over year. Research and development (R&D) expenses are the costs associated with the development of new products, technologies, or improvements to existing products.

AptarGroup, Inc. Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 570.64 M, a 4.39% change year over year.
AptarGroup, Inc. Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 546.64 M, a -2.81% change year over year.
AptarGroup, Inc. Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 562.43 M, a 45.99% change year over year.
AptarGroup, Inc. Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 385.26 M, a 25.04% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Research and Development (R&D) Expenses	Revenue	Revenue	Gross Profit

NYSE: ATR

AptarGroup, Inc.

CEO	Mr. Stephan B. Tanda
IPO Date	April 23, 1993
Location	United States
Headquarters	265 Exchange Drive
Employees	13,000
Sector	🛍 Consumer Discretionary
Industries Personal Care 🔬 Chemicals & Advanced Materials 💄 Cosmetics 💊 Drugstores & Retail Pharmacies 🛍 Specialty Retail

Description

AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.